Similar articles for PMID: 30842175

Year	Number of Results
1999	1
2002	1
2004	1
2005	1
2006	1
2007	2
2008	1
2009	4
2010	1
2011	1
2012	2
2013	10
2014	6
2015	15
2016	12
2017	10
2018	9
2019	4
2024	0

1

Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study.

Cho BC, DE Pas T, Kalofonos H, Wang Q, Ramlau R, Cheng Y, Vitiello F, Laisaar T, Vallières E, Kubisa B, Orlov S, Park K, Debruyne C, Vansteenkiste J. Cho BC, et al. Anticancer Res. 2019 Mar;39(3):1403-1409. doi: 10.21873/anticanres.13255. Anticancer Res. 2019. PMID: 30842175 Clinical Trial.

2

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.

Vansteenkiste JF, Cho BC, Vanakesa T, De Pas T, Zielinski M, Kim MS, Jassem J, Yoshimura M, Dahabreh J, Nakayama H, Havel L, Kondo H, Mitsudomi T, Zarogoulidis K, Gladkov OA, Udud K, Tada H, Hoffman H, Bugge A, Taylor P, Gonzalez EE, Liao ML, He J, Pujol JL, Louahed J, Debois M, Brichard V, Debruyne C, Therasse P, Altorki N. Vansteenkiste JF, et al. Lancet Oncol. 2016 Jun;17(6):822-835. doi: 10.1016/S1470-2045(16)00099-1. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27132212 Clinical Trial.

3

Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.

Feng W, Li Y, Shen L, Cai XW, Zhu ZF, Chang JH, Xiang JQ, Zhang YW, Chen HQ, Fu XL. Feng W, et al. Oncotarget. 2016 Feb 9;7(6):7227-40. doi: 10.18632/oncotarget.6979. Oncotarget. 2016. PMID: 26811495 Free PMC article.

4

The prognostic impact of tumor volume on stage I non-small cell lung cancer.

Su XD, Xie HJ, Liu QW, Mo YX, Long H, Rong TH. Su XD, et al. Lung Cancer. 2017 Feb;104:91-97. doi: 10.1016/j.lungcan.2016.12.013. Epub 2016 Dec 21. Lung Cancer. 2017. PMID: 28213008

5

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.

Kelly K, Altorki NK, Eberhardt WE, O'Brien ME, Spigel DR, Crinò L, Tsai CM, Kim JH, Cho EK, Hoffman PC, Orlov SV, Serwatowski P, Wang J, Foley MA, Horan JD, Shepherd FA. Kelly K, et al. J Clin Oncol. 2015 Dec 1;33(34):4007-14. doi: 10.1200/JCO.2015.61.8918. Epub 2015 Aug 31. J Clin Oncol. 2015. PMID: 26324372 Clinical Trial.

6

The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.

Jao K, Tomasini P, Kamel-Reid S, Korpanty GJ, Mascaux C, Sakashita S, Labbé C, Leighl NB, Liu G, Feld R, Bradbury PA, Hwang DM, Pintilie M, Tsao MS, Shepherd FA. Jao K, et al. Lung Cancer. 2018 Sep;123:22-29. doi: 10.1016/j.lungcan.2018.06.023. Epub 2018 Jun 19. Lung Cancer. 2018. PMID: 30089591

7

Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer.

Takada K, Shimokawa M, Akamine T, Ono Y, Haro A, Osoegawa A, Tagawa T, Mori M. Takada K, et al. Anticancer Res. 2019 Apr;39(4):1987-1996. doi: 10.21873/anticanres.13309. Anticancer Res. 2019. PMID: 30952742

8

Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.

Su C, Xu Y, Li X, Ren S, Zhao C, Hou L, Ye Z, Zhou C. Su C, et al. Int J Clin Exp Pathol. 2015 May 1;8(5):5509-18. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191258 Free PMC article.

9

Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.

Yoo C, Yoon S, Lee DH, Park SI, Kim DK, Kim YH, Kim HR, Choi SH, Kim WS, Choi CM, Jang SJ, Song SY, Kim SS, Choi EK, Lee JC, Suh C, Lee JS, Kim SW. Yoo C, et al. Clin Lung Cancer. 2015 Nov;16(6):e203-12. doi: 10.1016/j.cllc.2015.04.004. Epub 2015 Apr 23. Clin Lung Cancer. 2015. PMID: 25997733

10

Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S. Rieber J, et al. Lung Cancer. 2016 Jan;91:41-7. doi: 10.1016/j.lungcan.2015.11.014. Epub 2015 Nov 25. Lung Cancer. 2016. PMID: 26711933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

74 results

Results by year